Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shoichi Iriguchi

Showing results (21-30 of 24) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 24 results.
Nature Biomedical Engineering|December 12, 2022
Optimization of the proliferation and persistency of CAR T cells derived from human induced pluripotent stem cellsTatsuki Ueda, Sara Shiina, Shoichi Iriguchi, et al.
Nature Communications|January 19, 2021
A clinically applicable and scalable method to regenerate T-cells from iPSCs for off-the-shelf T-cell immunotherapyShoichi Iriguchi, Yutaka Yasui, Yohei Kawai, et al.
Cell Stem Cell|November 20, 2018
Enhancing T Cell Receptor Stability in Rejuvenated iPSC-Derived T Cells Improves Their Use in Cancer ImmunotherapyAtsutaka Minagawa, Toshiaki Yoshikawa, Masaki Yasukawa, et al.
Cell Stem Cell|January 8, 2013
Generation of rejuvenated antigen-specific T cells by reprogramming to pluripotency and redifferentiationToshinobu Nishimura, Shin Kaneko, Ai Kawana-Tachikawa, et al.
Pageof 3

Showing results (21-30 of 24) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 24 results.
Nature Biomedical Engineering|December 12, 2022
Optimization of the proliferation and persistency of CAR T cells derived from human induced pluripotent stem cellsTatsuki Ueda, Sara Shiina, Shoichi Iriguchi, et al.
Nature Communications|January 19, 2021
A clinically applicable and scalable method to regenerate T-cells from iPSCs for off-the-shelf T-cell immunotherapyShoichi Iriguchi, Yutaka Yasui, Yohei Kawai, et al.
Cell Stem Cell|November 20, 2018
Enhancing T Cell Receptor Stability in Rejuvenated iPSC-Derived T Cells Improves Their Use in Cancer ImmunotherapyAtsutaka Minagawa, Toshiaki Yoshikawa, Masaki Yasukawa, et al.
Cell Stem Cell|January 8, 2013
Generation of rejuvenated antigen-specific T cells by reprogramming to pluripotency and redifferentiationToshinobu Nishimura, Shin Kaneko, Ai Kawana-Tachikawa, et al.
Pageof 3